A Study to Investigate the Improvement of Sensitivity of a New Contrast Enhanced Ultrasound (CEUS) Technology Over Those of Traditional CEUS

Overview

About this study

The overall goal of this study is to investigate the improvement of sensitivity and penetration of a new contrast enhanced ultrasound (CEUS) technology over those of traditional CEUS.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with clinically indicated contrast enhanced ultrasound imaging.
  • Patients age above 18 years old.

Exclusion Criteria:

  • Patients with any adverse reactions to the preceding clinically indicated CEUS imaging. 
  • Pregnant women.
  • Nursing mother.
  • Patients with known or suspected right-to-left, bi-directional, or transient right-to-left cardiac shunts. 
  • Patients with history of hypersensitivity allergic reactions to ultrasound contrast agents. 
  • Patients lacking capacity to consent. 
  • Vulnerable subjects such as prisoners.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Open for enrollment

Contact information:

Theresa Nielson C.C.R.C.

(507)422-0743

Nielson.Theresa@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20359115

Mayo Clinic Footer